Ginkgo Biloba Research Today is a free monthly online journal that collates and summarizes the latest research about Ginkgo Biloba, including details on ginkgo biloba, herbal remedies, side effects, benefits.

Intra-uterine growth retardation after prenatal administration of Ginkgo biloba to rats.

Pinto RM, Fernandes ES, Reis JE, Peters VM, Guerra Mde O

Centro de Biologia da Reprodução, Federal University of Juiz de Fora, Caixa, Postal 328, CEP 36001-970 Juiz de Fora, MG, Brazil.

Ginkgo biloba is a plant used in the treatment of Alzheimer's disease, cerebrovascular insufficiency and peripheral vascular diseases that showed reproductive toxicity in vitro and in the mouse model. In this study, pregnant Wistar rats received 0, 3.5, 7 and 14mg/kgbodyweight/day of G. biloba, by gavage, from the 8th to 20th day of pregnancy. Rats were killed on the 21st day and the following parameters were evaluated: maternal body weight; food and water intake; maternal's liver, kidney and ovary weights; resorption index; post-implantation loss; mean of live fetuses; fetuses and placenta mean weight; fetuses' liver, kidney, lung and brain weights; fetuses' external malformations. No significant alteration was observed in maternal parameters of toxicity, but the treatment with 7 and 14mg/kg/day of G. biloba caused significant decrease in the fetuses mean weights. The results indicated that G. biloba was not toxic to mothers, although it caused fetal intra-uterine growth retardation.

Published 21 May 2007 in Reprod Toxicol, 23(4): 480-5.
Full-text of this article is available online (may require subscription).

© 2004-2008 Ginkgo Biloba Research Today. All Rights Reserved.